Breaking News


EXPRESS: Stroke in COVID-19: a systematic review and meta-analysis

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial

Remdesivir for the Treatment of Covid-19 — Final Report

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Ischemic Stroke Occurs Less Frequently in Patients With COVID-19 A Multicenter Cross-Sectional Study

Postmortem Neuropathology in COVID-19

Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders

Cerebrospinal Fluid Leak After Nasal Swab Testing for Coronavirus Disease 2019

Genomic evidence for reinfection with SARS-CoV-2: a case study

Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study

Neuropathology of patients with COVID-19 in Germany: a post-mortem case series

COVID-19 impact on consecutive neurological patients admitted to the emergency department

CSF biomarkers in patients with COVID-19 and neurological symptoms A case series

Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series

Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia

Severe COVID-19-related encephalitis can respond to immunotherapy

New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review

Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas

Tackling challenges in care of Alzheimer’s disease and other dementias amid the COVID-19 pandemic, now and in the future

Virology, transmission, and pathogenesis of SARS-CoV-2

Considerations for diagnostic COVID-19 tests

Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses

Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown

The cognitive consequences of the COVID-19 epidemic: collateral damage?

COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management

Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China

The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries


Ultrasound neuromodulation therapy meets clinical practice

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases

Electroencephalographic findings in COVID-19 patients: A systematic review

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'

Humoral Immune Response to SARS-CoV-2 in Iceland

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts

Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis

Multiple sclerosis and COVID‐19: how many are at risk?

COVID-19 case fatality and Parkinson’s disease

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia

The effect of the COVID-19 pandemic on people with Parkinson's disease

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome studies in 8 stuporous and comatose patients

Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid‐19

Risk factors for intracerebral hemorrhage in patients with COVID‐19

Clinical and neuroimaging correlation in patients with COVID-19

COVID-19 in Parkinson's disease: Report on prevalence and outcome

Neuro-ophthalmic manifestations of coronavirus disease 19

The spectrum of neuropathology in COVID-19

SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?

The impact of COVID-19 on epilepsy care: a survey of the American Epilepsy Society membership

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

Persistent symptoms in patients after acute COVID-19

Neurobiology of COVID-19

Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description

COVID-19 and decompressive hemicraniectomy for acute ischemic stroke

Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID‐19

Characteristics and outcomes in patients with COVID-19 and acute ischaemic stroke. The global COVID-19 stroke registry

Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection

Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19) a review

Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in north-west Spain

Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 Coronavirus

The COVID-19 pandemic and neurology

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

New onset neurologic events in people with COVID-19 infection in three regions in China

Incidence and case fatality rate of COVID-19 in patients with active epilepsy

COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center

Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study

Patterns of smell recovery in 751 patients affected by the COVID‐19 outbreak

Assessment of neurological manifestations in hospitalized patients with COVID‐19

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Neurological associations of COVID-19

Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington state: a case series

Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza

Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019 – the GRECCO-19 randomized clinical trial

Neurologic and radiographic findings associated with COVID-19 infection in children

Factors associated with death in critically ill patients with coronavirus disease 2019 in the US

Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy

An mRNA vaccine against SARS-CoV-2 — preliminary report

Dexamethasone in hospitalized patients with COVID-19 — Preliminary Report

COVID-19 presenting with ophthalmoparesis from cranial nerve palsy

Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection

Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection

Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)

Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas

Recommendations for Deep Brain Stimulation Device Management During a Pandemic

COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care

An Italian programme for COVID-19 infection in multiple sclerosis

COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach

COVID-19 infection in a patient with multiple sclerosis treated with fingolimod

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study

Interpreting Diagnostic Tests for SARS-CoV-2

Guidance on Stroke Managment during COVID-19 Pandemic

Recently released guidance on stroke management during the current COVID-19 pandemic emphasises carefully managed triage, importance of appropriate personal protective equipment, and crisis resource management.

Click on the links below to access the guidance material:

AHA temporary emergency guidance about acute stroke management in COVID pandemic

Protected stroke code

Breaking News articles on EANpages are categorized into different colors, according to their level of evidence.